Skip to main content

HELP · Helus Pharma Inc. · Exempt Offerings

Track HELP — free
$6.76 -0.02 (-0.29%) Play latest call Q2 2026 earnings call transcript
Market Cap
$541.16M
Shares
79.82M
Volume · Nov 19 2.06M Avg daily vol (3M) 1.83M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2026-09-01 New $261,987 $0
2026-08-19 New Indefinite $0
2026-08-19 New Indefinite $0
2026-07-16 New $511,720 $0
2026-07-16 New Indefinite $0
2026-03-23 New Indefinite $0
2026-01-12 New $114,154 $0
2025-11-26 New $288,580 $0
2025-10-15 New $601,865 $0
2025-09-23 New $120,070 $0
2025-08-27 New $288,280 $0
2025-08-27 New $637,404 $0
2025-07-10 New $50,000,000 $50,000,000
2024-12-10 New $748,395 $0
2024-09-09 New $3,249,666 $0
2024-04-22 New $1,904,692 $0
2024-04-03 New $108,699,999 $108,699,999
2023-11-29 New $1,690,000 $0
2023-07-10 New $1,991,037 $0
2022-04-28 New $2,892,247 $2,892,247
2022-04-28 New $342,513 $342,513
2022-03-22 New $317,098 $317,098
2022-03-21 New $17,725 $17,725
2020-11-20 New $26,393,081 $26,393,081
2020-11-20 New $132,174 $0
2020-11-20 New $35,308 $0
2020-11-20 New $392,307 $0
Showing 1–27 of 27 filings
Key facts CIK 1833141 CUSIP 423492107 13F (30d) 103 filings 101 filers Visit website Investor relations